Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label safety study of istradefylline in Parkinson's disease patients with motor response complications on levodopa
2004-002844-93Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Istradefylline in Parkinson's disease (PD), sponsored by Kyowa Kirin. Primary endpoint: Long-term safety and tolerability of istradefylline. Started Jan 2005; status: completed.
02
Drugs
Istradefylline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2004-002844-93.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002844-93.